Clinical Trial Update: CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating CHG-based chemotherapy in combination with venetoclax and azacitidine for newly diagnosed acute myeloid leukemia; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: NOT_YET_RECRUITING